Back to search
FDAFDA · Food and drugs·Recall number Z-0368-2016

PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.

Published December 9, 2015 · Recall initiated: October 26, 2015

Summary

FDA records medical device Class II recall Z-0368-2016, published December 9, 2015 and initiated October 26, 2015. Recalling firm: Merz North America, Inc.; Status: Terminated; Reported quantity: 9,439 units; Lot: Lot Number 100076901, 100077013, 100077249, 100077250, 100078691, 100079054, 100079213, 100079597, 100079954, 100080082, 100081008, 100081401, 100081573, 100081916, 100082248, 100082468, 100082695, 100082729, 100083126, 100083785, 100083934. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Merz North America, Inc.
Distributor
Distributed US (nationwide) including the Virgin Islands and South Africa.
Lot
Lot Number 100076901, 100077013, 100077249, 100077250, 100078691, 100079054, 100079213, 100079597, 100079954, 100080082, 100081008, 100081401, 100081573, 100081916, 100082248, 100082468, 100082695, 100082729, 100083126, 100083785, 100083934
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency. recalled?

Yes. FDA published recall Z-0368-2016 on December 9, 2015. Reported hazard: The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.

What should I do if I have this product?

Voluntary: Firm initiated · Letter